header logo image


Page 839«..1020..838839840841..850860..»

This weeks best home entertainment: from The Morning Show to For Sama – The Guardian

October 27th, 2019 9:46 am

Yet another streaming contender enters the fray as passably successful tech company Apple launches a TV arm. As you would expect, it has got some big names onboard for its opening effort, a satire about a popular but troubled TV show. Jennifer Aniston, Reese Witherspoon, Steve Carell and Gugu Mbatha-Raw star.From Friday, Apple TV+

David Attenborough returns with another of his spirit-restoring natural history epics. This series tracks life on every continent, focusing on the challenges faced by the flora and fauna found there. We begin in a surprisingly bountiful Antarctica.Sunday, 6.15pm, BBC One

Channel 4s annual Indian film season returns with another nicely curated selection of treats. Highlights include Trapped, Manmarziyaan and Happy Phirr Bhag Jayegi. Most notable is the UK premiere of Shashanka Ghoshs buddy comedy Veere Di Wedding, which became one of the highest-grossing Indian films to feature a female lead.From Monday, Channel 4

A second series from the makers of Dr Death, a podcast about medical malpractice. This new pod explores stem-cell therapy, which is often posited as a miracle cure but harbours its own share of horror stories. Californian company Liveyon goes under the microscope here.Podcast

More disarming but prescient nerd banter as this excellent tech drama begins its final season. Silicon Valley has done a superb job of balancing the critical nature of the issues it explores with the inevitable comedy arising from many of the individuals involved. This last run will be no exception: Pied Piper has become a big player but expect scandals around data-harvesting to hit it hard.Monday, 10.10pm, Sky Atlantic

A heart-wrenching take on the war in Syria from film-maker Waad al-Kateab, whose husband volunteers in a hospital in Aleppo, and her attempts to raise a child amid the citys carnage. A heroic and unmissable act of documentation, shot through with fear, horror and love.Saturday, 9pm, Channel 4

Vladimir Putins Russia often seems to be a peculiar mixture of horror and comedy, and this documentary looking at Russian state TV captures that uneasy tone perfectly. Expect the odd topless hunting expedition but also the occasional glimpse of the iron fist lurking inside the velvet glove.Wednesday, 10pm, Channel 4

This season of the bun bonanza comes to a close. With the top prize at stake and relatives waiting expectantly outside the tent, Paul and Prue are rather cruelly charging the finalists with making souffles. Whose will rise and whose will fall?Tuesday, 8pm, Channel 4

The biblical trials of Job are transposed to modern Russia in Andrey Zvyagintsevs powerhouse drama of endemic corruption. Aleksei Serebryakov is the embattled Kolya, struggling vainly to prevent eviction from the family home by unscrupulous authorities. It is both a small-scale story of vodka-soaked despair and a tragedy on a universal scale.Saturday, 12.10am, BBC Two

The Fab Five apparently made the decision to take their empathic ebullience to Japan following a lengthy exchange of group texts with Japanese model and actor Kiko Mizuhara. So expect a guest appearance from her and also a visit from comedian Naomi Watanabe. Otherwise, its life-coaching business as usual as four Tokyo natives get makeovers.From Friday, Netflix

Go here to read the rest:
This weeks best home entertainment: from The Morning Show to For Sama - The Guardian

Read More...

4 reporters break down the DOJ criminal probe and more impeachment bombshells – POLITICO

October 27th, 2019 9:46 am

Melanie Zanona, congressional reporter: The GOP raid on the secure facility where interviews with impeachment witnesses have been taking place. It was quite the scene Ive never seen anything like it in all my years covering Congress. The sergeant at arms even had to be called in at one point to defuse the situation and perform a security sweep because Republicans were violating the strict no cell phone use rules.

Josh Gerstein, legal affairs contributor: Probably what I got to witness first-hand, which was a defense lawyer for one of Rudy Giulianis associates, Lev Parnas, tell a federal judge that some of the evidence the government has collected in the straw-donor and foreign-donations case may not be usable because Parnas and Giuliani were working for the president of the United States. Giuliani hasnt been charged, of course, but when he was the swashbuckling top federal prosecutor in New York in the 1980s could anyone have predicted that his activities would be intimately connected to a case being prosecuted by that same office?

Nahal : Ive been fascinated by Rudy Giuliani for many years, so Im eyeing with interest the various criminal probes into his actions. Im not an expert on the Bard, but there has to be a Shakespeare play that captures the arc of Giulianis life and career. He will probably say its Much Ado About Nothing.

Natasha: The Giuliani investigation just got a lot more interesting, in light of new reporting from our colleague Darren Samuelsohn about the Justice Departments Criminal Division jumping into the fray. The other one to watch, of course, is the continuing probe out of the Southern District of New York into Giulianis two associates, Parnas and Igor Fruman, who were indicted on campaign finance charges earlier this month. Both men have pleaded not guilty.

Melanie: We now know the Justice Department has opened a criminal investigation into itself. DOJ has transitioned from an administrative review into the origins of its Russia probe which Trump has repeatedly decried as a "hoax" despite mounds of evidence to the contrary to a criminal inquiry with subpoena and grand jury power. The news raised eyebrows in D.C., with some Democrats worried that the the department is acting like Trumps political attack dog instead of an independent law enforcement agency.

Josh: Like other Justice Department reporters, Im fascinated by this new criminal investigation and what the grounds or the predicate as they call it here for launching it. No one seems to have nailed that down yet. Some possibilities: the inspector general investigation stumbled across evidence that someone was illegally leaking to the press about the Trump-Russia probe; the IG thinks someone lied to them, to Congress or to the courts; or someone may have been conducting some surveillance or other investigate tactic that may have been illegal. I guess its remotely possible that the alleged crime has to do with the decision to launch the Trump-Russia inquiry in the first place or anti-Trump bias on the part of officials involved, but its hard to see how that itself can be torqued into a criminal case.

Nahal: I believe it will say that at the very least such an action would open the president to being investigated. Im not sure about prosecuted, at least not while hes in office.

Melanie: That was a shocking argument to many observers and likely to the judges as well. Essentially, Trumps lawyers are saying the president is above the law (although they did acknowledge that Trump could be criminally prosecuted once he leaves office).

Josh: Its a headline-grabber to be sure, but Im not sure its a question that the court has to answer directly in order to address the issue before them about turning over Trumps tax returns to the Manhattan D.A. A real weak point in the Trump legal teams argument is that they seem to be contending Trump has the right to keep any evidence about him away from investigators even if they want to use it to charge others. Even if a president does have some immunity, does that extend to all of his family members and business associates? I cant see any court adopting that stance.

Nahal: As a strategy it actually seemed pretty smart to me. At this stage, they have very little they can say on the substance of the impeachment inquirys findings. So they want to muddy the picture the public has of the process but claiming, often misleadingly, that it is unfair. They managed to do that, as well as changing the headlines for a few hours. They also showed the GOP base that they remain loyal to Trump.

Natasha: A stunt more than a strategy, and transparently so given how many Republicans currently have access to the closed-door depositions by virtue of their membership on the relevant committees including ones who participated in the crash of the SCIF on Wednesday.

See more here:
4 reporters break down the DOJ criminal probe and more impeachment bombshells - POLITICO

Read More...

Induced Pluripotent Stem Cell Market Sustains Competitiveness by Adoption of Technological Innovations – Health News Office

October 27th, 2019 9:46 am

Global Single-Phase Voltage Monitoring Relays Market Report 2019 Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Single-Phase Voltage Monitoring Relays industry.

The report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Make An EnquiryAbout This Report @ https://www.researchmoz.us/enquiry.php?type=E&repid=2518510&source=atm

For competitor segment, the report includes global key players of Single-Phase Voltage Monitoring Relays as well as some small players.

AppleSamsungCreative TechnologySanDiskSonyArchosMicrosoftKoninklijke PhilipsCoby ElectronicsCinepal

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeAudioVideo

Segment by ApplicationOnline SalesOffline Sales

Request Sample Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2518510&source=atm

Important Key questions answered in Single-Phase Voltage Monitoring Relays market report:

What will the market growth rate, Overview, and Analysis by Type of Single-Phase Voltage Monitoring Relays in 2024?

What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Single-Phase Voltage Monitoring Relays market?

What is Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles?

Who Are Opportunities, Risk and Driving Force of Single-Phase Voltage Monitoring Relays market? Knows Upstream Raw Materials Sourcing and Downstream Buyers.

Who are the key manufacturers in space? Business Overview by Type, Applications, Gross Margin, and Market Share

What are the opportunities and threats faced by manufacturers in the global market?

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2518510&licType=S&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Single-Phase Voltage Monitoring Relays product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Single-Phase Voltage Monitoring Relays , with price, sales, revenue and global market share of Single-Phase Voltage Monitoring Relays in 2019 and 2015.

Chapter 3, the Single-Phase Voltage Monitoring Relays competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Single-Phase Voltage Monitoring Relays breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2019 to 2025.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2019 to 2025.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2019 to 2025.

Chapter 12, Single-Phase Voltage Monitoring Relays market forecast, by regions, type and application, with sales and revenue, from 2019 to 2025.

Chapter 13, 14 and 15, to describe Single-Phase Voltage Monitoring Relays sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Excerpt from:
Induced Pluripotent Stem Cell Market Sustains Competitiveness by Adoption of Technological Innovations - Health News Office

Read More...

5G Health Risks: Here’s What the Experts Say – Tom’s Guide

October 27th, 2019 9:46 am

This year has delivered a whirlwind of hype surrounding 5G: how it will change lives, where 5G networks are launching around the world and when exactly your smartphone will be capable of lightning-fast speeds. But some people are concerned that the rollout of 5G is happening so quickly that we don't truly understand if or how the launch of next-generation connectivity will bring unintended health consequences.

The short answer: The scientific consensus is that 5G, like 3G and 4G before it, is not harmful to your health. In August, the U.S. Federal Communications Commission (FCC) officially determined that 5G's radio waves are safe.

But that finding probably won't stem the tide of worry over 5G's rollout, especially as more 5G phones hit the market and the coverage becomes more widespread.

Early 5G networks including those launched by AT&T, Verizon and T-Mobile use high-frequency, millimeter-wave (mmWave) spectrum to deliver faster speeds. Some people are concerned that those radio waves, along with the additional cellular infrastructure needed to build out mmWave-based 5G networks in major cities, will increase the amount of radiation in the environment.

The scientific consensus is that there are no known health risks from all forms of RF energy at the low levels approved for everyday consumer use.

Millimeter-wave spectrum has never been used for telecommunications. However, that's not because it's dangerous; the higher-frequency bands are just not as effective at transmitting data across distances. An mmWave-based 5G signal can't penetrate objects, such as glass windows or concrete buildings. It also can't penetrate the body.

The concerns over 5G are an extension of the worries some people have about cellphones in general.

There are two types of radiation: ionizing and non-ionizing. Ultra-high-frequency ionizing radiation which includes gamma-rays, UV rays from the sun and X-rays is harmful to humans because it penetrates the body at the cellular level and causes electrons and atoms to break apart. Ionizing radiation can cause cancer, which is why you're supposed to wear sunscreen outdoors and avoid unnecessary medical X-rays.

(Image credit: Shutterstock)

Non-ionizing radiation does not cause cancer, and runs the gamut from FM radio waves to visible light. In between the two is 5G, which operates at a slightly higher frequency than 3G and 4G.

The FCC requires all electronic equipment sold in the U.S. to meet the agency's safety standards for acceptable radio-frequency (RF) energy by determining the device's specific absorption rate (SAR), or the rate by which the body absorbs RF energy. The FCC recently reevaluated its standards, which were created in 1996, when determining the safety of 5G. The recommended RF exposure limits remain unchanged.

MORE: What Is 5G? The Definitive Guide to the 5G Network Rollout

"The scientific consensus is that there are no known health risks from all forms of RF energy at the low levels approved for everyday consumer use," a spokesperson for CTIA, a trade group for the wireless communications industry, said in an emailed statement. "The FCC regulates RF emissions, including millimeter waves from 5G devices and equipment, and has adopted the recommendations of expert scientific organizations that have reviewed the science, including dozens of studies focused specifically on millimeter waves, and established safe exposure levels."

There are a few factors contributing to the concern or outright fear of 5G's effects.

(Image credit: Shutterstock)

The first is scientific research that has been interpreted by some to support concern about cellphone radiation. For instance, a 2018 study released by the National Toxicology Program (NTP) found that when rats and mice were exposed to radio-frequency waves like the kind that emanate from cellphones, they developed malignant tumors. This particular study looked at 2G and 3G phones. However, that doesn't mean 5G will cause cancerous tumors in humans.

Skeptics, like the University of California, Berkeley's Joel Moskowitz, are calling for a halt to 5G's rollout.

"The exposures used in the studies cannot be compared directly to the exposure that humans experience when using a cellphone," John Bucher, a senior scientist for the NTP, said when announcing the findings. "In our studies, rats and mice received radio-frequency radiation across their whole bodies. By contrast, people are mostly exposed in specific local tissues close to where they hold the phone. In addition, the exposure levels and durations in our studies were greater than what people experience."

The NTP has said it plans to develop thorough studies to evaluate the safety of 5G.

The World Health Organization's International Agency for Research on Cancer has categorized RF waves from cellphones as a possible carcinogen, which is another factor contributing to the concerns over 5G. But, for context, an ingredient in coffee is also considered a possible carcinogen. Red meat is categorized as a probable carcinogen, which means it has a stronger link to cancer than cellphones do.

MORE: 5G Phones: Every Known Phone and Release Date

The New York Times reported earlier this year that one of the primary 5G fearmongers is Russian propaganda spreading on YouTube, Facebook and blogs across the internet. Videos and news articles filled with misinformation are scaring U.S. consumers even as Russia proceeds with its own 5G plans.

5G is a new standard for wireless communication, but from a technological standpoint, it isn't all that different from 3G and 4G. The radio-frequency waves from 5G cellphones are akin to the RF waves from LTE devices (i.e., non-ionizing). According to the American Cancer Society, most studies have shown that "the RF waves given off by cell phones don't have enough energy to damage DNA directly or to heat body tissues."

(Image credit: Tom's Guide)

In 2000, a now-debunked study on the effect of radio waves on brain tissue fueled conspiracy theories about cellphones and radiation. The author of the study, physicist Bill Curry, claimed that wireless devices could cause brain cancer in humans. According to The New York Times, Curry neglected to take into account that our skin protects our internal tissues from high-frequency radio waves (which is, again, why you need to wear sunscreen to protect the skin from even higher-frequency UV rays).

"If you're more concerned about the base station on your building than you are [about] spending an hour in the noonday sun without any protection, you might want to think about your priorities."

However, because 5G networks are just now getting off the ground with a new roster of 5G phones, no long-term studies of the network or the devices and their effects on humans have been conducted. In addition, the types of devices we use and the way we use them are constantly changing. For that reason, skeptics such as Joel Moskowitz, director of the Center for Family and Community Health at the University of California, Berkeley School of Public Health, are calling for a halt to 5G's rollout.

Moskowitz said it would be unethical to conduct a conclusive scientific study on human beings controlling for the health effects of cellphone radiation, so researchers rely on observational and animal studies. Those studies haven't proved conclusively that cellphones are harmful to humans, but Moskowitz thinks there's enough evidence to "put a moratorium on the rollout of new technologies" like 5G infrastructure build-out until more research is done.

"I'm certain that, within the next five years, radio-frequency radiation will be declared at least probably carcinogenic [by the WHO]," Moskowitz said.

But Christopher Collins, a professor in New York University's radiology department who studies the safety of electromagnetic fields, said the lack of 5G-specific research doesn't mean researchers are starting from scratch when evaluating 5G's potential effects on human health.

MORE: Here's Why Apple's 5G iPhone Isn't Coming Until 2020

"A lot of the premise of people who advocate against 5G or wireless communications fields in general seem to suggest that we just don't know and we need to do more studies," Collins said. "We know a lot. We've been doing experiments on humans and animals for decades over this entire spectrum."

Collins said scientists "never want to say the book is closed," but based on what we already know, there's no evidence to suggest that 5G will cause cancer or other detrimental health effects in most people.

Prior to the FCC's 5G safety determination, city and state regulators were hearing from residents who were concerned that not enough was known about 5G. Specifically, people are concerned that the density of small cell sites required to build out mmWave-based 5G networks would emit dangerous amounts of radiation.

The FCC's 5G FAST Plan, which requires municipalities to approve 5G cell sites within 60 to 90 days, has caused concern. Carriers are moving quickly to build out infrastructure without giving residents notice, The Wall Street Journal reported, and local legislators are pushing back. Some 90 cities and counties have filed suit against the FCC in a case currently pending in the Ninth Circuit Court of Appeals.

Homeowners may not want new antennas outside their homes for aesthetic reasons, or because they want advance notice when changes occur in their communities, but the FCC, industry trade groups and many scientists maintain there is no proven health risk.

MORE: 5 Ways 5G Will Change Your Life

"Typical exposure to 5G devices such as small cells attached to phone poles or the sides of buildings is far below the permissible levels and comparable to Bluetooth devices and baby monitors," the CTIA spokesperson said. "The FCC continues to monitor the science to ensure that its regulations are protective of public health."

Or, as NYU's Chris Collins put it:

One thing that we know can cause cancer is sunlight. People would generally do better to worry about that than the exposure levels we're talking about with cellphones. If you're more concerned about the base station on your building than you are [about] spending an hour in the noonday sun without any protection, you might want to think about your priorities."

Scientists and researchers will keep studying radio-frequency waves, including 5G, to add to the existing body of research. But without replicable, concrete proof that radiation from cellphones or wireless networks causes serious adverse health effects in humans, Collins said, there's no reason to stop the rollout of 5G.

"Is it time to stop questioning? No, it's never time to stop questioning," he said. "It's important to remember that, based on what we know now, there is no effect except for heating. This is based on many decades' worth of study in these fields. It's another thing to say, 'Should we stop progress?' based on what I would call unfounded concerns. I am quite certain there's nothing to be alarmed about for millimeter waves."

If you are concerned, there are ways to mitigate your personal exposure to cellphone radiation by using fewer wireless devices. That might also do wonders for your mental health, too.

Read the original:
5G Health Risks: Here's What the Experts Say - Tom's Guide

Read More...

Higher Education Market Industry Analysis, Opportunity Assessment and Forecast up to 2016 2023 – Health News Office

October 27th, 2019 9:46 am

Global Single-Phase Voltage Monitoring Relays Market Report 2019 Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Single-Phase Voltage Monitoring Relays industry.

The report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Make An EnquiryAbout This Report @ https://www.researchmoz.us/enquiry.php?type=E&repid=2518510&source=atm

For competitor segment, the report includes global key players of Single-Phase Voltage Monitoring Relays as well as some small players.

AppleSamsungCreative TechnologySanDiskSonyArchosMicrosoftKoninklijke PhilipsCoby ElectronicsCinepal

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeAudioVideo

Segment by ApplicationOnline SalesOffline Sales

Request Sample Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2518510&source=atm

Important Key questions answered in Single-Phase Voltage Monitoring Relays market report:

What will the market growth rate, Overview, and Analysis by Type of Single-Phase Voltage Monitoring Relays in 2024?

What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Single-Phase Voltage Monitoring Relays market?

What is Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles?

Who Are Opportunities, Risk and Driving Force of Single-Phase Voltage Monitoring Relays market? Knows Upstream Raw Materials Sourcing and Downstream Buyers.

Who are the key manufacturers in space? Business Overview by Type, Applications, Gross Margin, and Market Share

What are the opportunities and threats faced by manufacturers in the global market?

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2518510&licType=S&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Single-Phase Voltage Monitoring Relays product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Single-Phase Voltage Monitoring Relays , with price, sales, revenue and global market share of Single-Phase Voltage Monitoring Relays in 2019 and 2015.

Chapter 3, the Single-Phase Voltage Monitoring Relays competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Single-Phase Voltage Monitoring Relays breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2019 to 2025.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2019 to 2025.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2019 to 2025.

Chapter 12, Single-Phase Voltage Monitoring Relays market forecast, by regions, type and application, with sales and revenue, from 2019 to 2025.

Chapter 13, 14 and 15, to describe Single-Phase Voltage Monitoring Relays sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Read more from the original source:
Higher Education Market Industry Analysis, Opportunity Assessment and Forecast up to 2016 2023 - Health News Office

Read More...

Cone Beam Computed Tomography Extremity Scanner Market Volume Analysis, Segments, Value Share and Key Trends 2018 2026 – Health News Office

October 27th, 2019 9:46 am

Global Single-Phase Voltage Monitoring Relays Market Report 2019 Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Single-Phase Voltage Monitoring Relays industry.

The report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Make An EnquiryAbout This Report @ https://www.researchmoz.us/enquiry.php?type=E&repid=2518510&source=atm

For competitor segment, the report includes global key players of Single-Phase Voltage Monitoring Relays as well as some small players.

AppleSamsungCreative TechnologySanDiskSonyArchosMicrosoftKoninklijke PhilipsCoby ElectronicsCinepal

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeAudioVideo

Segment by ApplicationOnline SalesOffline Sales

Request Sample Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2518510&source=atm

Important Key questions answered in Single-Phase Voltage Monitoring Relays market report:

What will the market growth rate, Overview, and Analysis by Type of Single-Phase Voltage Monitoring Relays in 2024?

What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Single-Phase Voltage Monitoring Relays market?

What is Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles?

Who Are Opportunities, Risk and Driving Force of Single-Phase Voltage Monitoring Relays market? Knows Upstream Raw Materials Sourcing and Downstream Buyers.

Who are the key manufacturers in space? Business Overview by Type, Applications, Gross Margin, and Market Share

What are the opportunities and threats faced by manufacturers in the global market?

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2518510&licType=S&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Single-Phase Voltage Monitoring Relays product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Single-Phase Voltage Monitoring Relays , with price, sales, revenue and global market share of Single-Phase Voltage Monitoring Relays in 2019 and 2015.

Chapter 3, the Single-Phase Voltage Monitoring Relays competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Single-Phase Voltage Monitoring Relays breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2019 to 2025.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2019 to 2025.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2019 to 2025.

Chapter 12, Single-Phase Voltage Monitoring Relays market forecast, by regions, type and application, with sales and revenue, from 2019 to 2025.

Chapter 13, 14 and 15, to describe Single-Phase Voltage Monitoring Relays sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Read the rest here:
Cone Beam Computed Tomography Extremity Scanner Market Volume Analysis, Segments, Value Share and Key Trends 2018 2026 - Health News Office

Read More...

Thinking about death: High neural activity is linked to shorter lifespans – Big Think

October 27th, 2019 9:44 am

If there's one thing that humans can't stop thinking about, it's death. But new research published in the journal Nature suggests that all that thinking might be the very thing that brings death on.

More precisely, researchers discovered that higher neural activity has a negative effect on longevity. Neural activity refers to the constant flow of electricity and signals throughout the brain, and excessive activity could be expressed in many ways; a sudden change in mood, a facial twitch, and so on.

"An exciting future area of research will be to determine how these findings relate to such higher-order human brain functions," said professor of genetics and study co-author Bruce Yankner. While it's probably not the case that thinking a thought reduces your lifespan in the same way smoking a cigarette does, the study didn't determine whether actual thinking had an impact on lifespan just neural activity in general.

To say this was an unexpected finding is an understatement. We expect that aging affects the brain, of course, but not that the brain affects aging. These results were so counterintuitive that the study took two additional years before it was published as the researchers gathered more data to convince their reviewers. Yankner was forbearing about the delay. "If you have a cat in your backyard, people believe you," he said. "If you say you have a zebra, they want more evidence."

Yankner and colleagues studied the nervous systems of a range of animals, including humans, mice, and Caenorhabditis elegans, or roundworm. What they found was that a protein called REST was the culprit behind high neural activity and faster aging.

First, they studied brain samples donated from deceased individuals aged between 60 and 100. Those that had lived longer specifically individuals who were 85 and up had unique gene expression profile in their brain cells. Genes related to neural excitation appeared to be underexpressed in these individuals. There was also significantly more REST protein in these cells, which made sense: REST's job is to regulate the expression of various genes, and it's also been shown to protect aging brains from diseases like dementia.

But in order to show that this wasn't simply a coincidence, Yankner and colleagues amplified the REST gene in roundworm and mice. With more REST came quieter nervous systems, and with quieter nervous systems came longer lifespans in both animal models.

Zullo et al., 2019

Normal mice (top) had much lower levels of neural activity than mice lacking the REST protein (bottom). Neural activity is color coded, with red indicating higher levels.

Higher levels of REST proteins appeared to activate a chain reaction that ultimately led to these increases in longevity. Specifically, REST suppressed the expression of genes that control for a variety of neural features related to excitation, like neurotransmitter receptors and the structure of synapses. The lower levels of activity activated a group of proteins known as forkhead transcription factors, which play a role in regulating the flow of genetic information in our cells. These transcription factors, in turn, affect a "longevity pathway" connected to signaling by the hormones insulin and insulin-like growth factor 1 (IGF1).

This longevity pathway has been identified by researchers before, often in connection with possible benefits to lifespan from fasting. Additionally, the insulin/IGF1 hormones are critical for cell metabolism and growth, features which relate to longevity in obvious ways.

The most exciting aspect of this research is that it offers targets for future research on longevity, possibly even allowing for the development of a longevity drug. For instance, anticonvulsant drugs work by suppressing the excessive neural firing that occurs during seizures, and in studies conducted on roundworms, they've also been shown to increase lifespan. This recent study shows that this connection might not be coincidental. Similarly, antidepressants that block serotonin activity have also been shown to increase lifespan. Dietary restriction has long been implicated in promoting longer lifespans as well. Dietary restriction lowers insulin/IGF1 signaling, which this study showed affects the REST protein and neural activity. More research will be needed to confirm or reject any of these possibilities, but all represent exciting new avenues to explore, possibly resulting in the extension of our lifespans.

From Your Site Articles

Related Articles Around the Web

Go here to see the original:
Thinking about death: High neural activity is linked to shorter lifespans - Big Think

Read More...

Does the human lifespan have a limit? – Varsity Online

October 27th, 2019 9:44 am

How many of us will see our 100th birthdays?DoD photo by U.S. Navy Petty Officer 2nd Class Kayla Jo Finley/Released

The maximum lifespan of an organism varies significantly between species, ranging from a single day for mayflies, to several hundred years for Greenland sharks. While the goal for most organisms at an evolutionary level is to reproduce, humanity continuously aimed at increasing our lifespan. Life expectancy is used as an indicator of a countries development, as well as a measure of social and scientific progress. A longer life would permit us to spend more time having valuable life experiences, make crucial contributions to our fields of work, potentially helping humanity progress further as a species.

Recent medical advances allow us to further pursue this quest. The average life expectancy in the U.K. is around 81 years currently significantly higher than the 35 years it was in the 17th century. We now live in an era of diseases of old age, where degenerative disorders such as dementia are dubbed the biggest health crisis of our time in developed countries. This poses an important question are our bodies biologically capable of sustaining the lifespans we strive for, or are we being overly ambitious?

Research into longevity is extremely complex and controversial. We only know of 48 people in history who have lived past the age of 115. It was already hypothesised in 1825 that mortality rates increase exponentially with age, implying that human life expectancy must tend towards a maximum value. A 2016 study claimed that even with a perfectly healthy lifestyle and access to medical interventions when necessary, the natural biological human age limit is approximately 115, with only a few individual outliers, in part due to their genetic architecture. This would imply that regardless of the technology we develop, it should be unable to increase our life expectancy past this limit.

This is a plausible suggestion when we consider ageing on a cellular level. The Hayflick limit refers to the number of times that most cells divide before entering senescence. Hayflick (currently a UCSF Professor of Anatomy at 91 years of age) proposed this theory in the 60s, after finding that a human cell population could only divide between 40 to 60 times in culture before entering senescence. Elizabeth Blackburn, Carol Greide and Jack Szostak went on to win a Nobel prize in 2009 for their discover that this correlates with telomeres (repetitive sequences of DNA at the ends of chromosomes that protect them) being reduced to a critical length, since these shorten after each cell division.

We only know of 48 people in history who have lived past the age of 115

Even if the body did not undergo any other processes of ageing, the accumulation of senescent cells would eventually cause death. Almost all senescent cells either self-destruct or are destroyed by the immune system, though a small number remain and have a strong signalling effect which can lead to chronic inflammation or disruption of nearby tissues and potentially even stimulate surrounding cells to become senescent. These processes are thought to be linked to the development of numerous age-related diseases, including Alzheimers and Type II diabetes. It appears that regardless of the condition the body is kept in, degenerative conditions will inevitably catch up with everyone.

Recent investigations carried out in Italy by observing lifespans of over 3,000 individuals over the age of 100 have revealed that annual mortality risks plateau by the age of 115 at around 50%. This is likely because any age related disorders that were to occur would have set in by this point. As a majority of diseases is associated with increasing age, we need to better understand what is driving ageing. We may be able to, through a mixture of medical, lifestyle, and environmental interventions push our life expectancy up.

But what about going further than, say, 115 years? While the early attempts at extending telomeres (using the enzyme telomerase) caused cells to become cancerous, more recent efforts using more controlled delivery systems are more promising at increasing lifespan without the added cancer risk. Promising results have recently arisen in the form of research carried out by the Spanish National Cancer Centre.

It could be possible for us to alter our susceptibility to the degenerative effects of age

The telomeres of mice embryonic stem cells were elongated beyond normal levels, and mice developing from these stem cells were generated. These mice had a 12.8% increase in median longevity, and an 8.4% increase in maximum longevity, compared to mice with normal telomere length. The mice also underwent less DNA damage as they aged, and showed lower cholesterol and LDL levels, as well as improved glucose and insulin tolerance.

Such research demonstrates that it could be possible for us to alter our susceptibility to the degenerative effects of age. Much remains to be discovered at what governs the rate of ageing, and then, whether reductions in the rate of ageing actually translate to longer lifespans, or simply to better health along the lifespan.

While many questions remain concerning the upper bound on lifespan, much could be done to increase life expectancy right now. In the last 100 years, the increase in life expectancy can be attributed to factors such as effective immunisation programs, antibiotics and public health initiatives around hygiene and sanitation. While life expectancies may appear to be approaching a plateau, many believe that developments in fields such as artificial intelligence and genetics could be responsible for our next surge in life expectancy by improving the ways in which we deliver healthcare. Some claim that it does not matter if our bodies degrade if we are able to develop technologies such as prosthesis and bionics.

While extending lifespan may seem like an exciting concept, this may pose additional challenges on both a societal and personal level. For instance, we are already struggling as a planet with overpopulation and its associated consequences, such as carbon emissions. Increased life expectancy has played a role in the development of this problem and may continue to do so. Many countries, such as Japan, have an aging population individuals aged 65 and older in Japan make up a quarter of its total population, estimated to increase to a third by 2050. Therefore, the dependency ratio (the proportion of workers to non-workers) creates a need for more efficient social care provision and strategies. .

Ageing is a natural process, and it may not necessarily be possible to halt the clock. As a species, we seem to have more control over how long we live than many other species do. In modern society, it is becoming increasingly more likely that excess of food or age related degenerative disorders will kill us rather than starvation or disease. However, if we do strive to push our life expectancies to new limits, it is vital that we consider the challenges this will pose for our bodies and society.

Originally posted here:
Does the human lifespan have a limit? - Varsity Online

Read More...

8 Science-Backed Things You Can Do Now To Add Years To Your Life – mindbodygreen.com

October 27th, 2019 9:44 am

Let's face it, just about everyone is looking for effective, safe ways to turn back the clock and boost longevity. If there were a switch we could flip to slow down the aging process (to counter the waning energy, to keep those memories sharp, to stay healthy enough to continue having amazing experiences), we'd probably all flip it in a heartbeat.

Unfortunately, there's no "fountain of youth" switch or pill just yet, and we can't stop aging altogether. But we do have significant influence over our longevity destiny, and we can slow aging with lifestyle and dietary changes that improve our body's ability to function optimally and repair itself. In fact, many top experts wholeheartedly believe in the saying, "Genetics loads the gun, lifestyle pulls the trigger."

"The thinking is that for the average person your genes influence about 25% of your longevity, and 75% is the environment," Robert Rountree, M.D., renowned integrative physician, recently told mbg.

Here, discover the small, sustainable, science-backed changesplus one really intriguing supplementthat may add quality years to your life.*

See the rest here:
8 Science-Backed Things You Can Do Now To Add Years To Your Life - mindbodygreen.com

Read More...

A Calm Mind Isn’t Just a Nice-to-Have. It Can Actually Help You Live Longer. – Thrive Global

October 27th, 2019 9:44 am

There are a lot of theories about the secret to a long life.

Dozens of research show the many benefits to remaining physically and mentally active as we get older the level of brain activity influence life span.

A newstudyfrom the Blavatnik Institute at Harvard Medical School suggests the secret to living longer may lie in the level of brain activity.

The authors linked long life to a quieter brain keep calm and carry on living a little longer, the research found. Excessive electrical activity in the brain was linked to shorter life spans. An overworked brain may hasten the ageing-related decline in memory and thinking skills.

Excessive brain activity is common in the digital age rushing from one task to another, constantly looking for something to stimulate us, whether thats a TV show or the notifications on our phone.

I think the implication of our study is that with ageing, there is some aberrant or deleterious neural activity that not only makes the brain less efficient, but is harmful to the physiology of the person or the animal, and reduces life span as a result,saysBruce Yankner, senior study author and professor of genetics at Harvard Medical School and co-director of the Paul F. Glenn Center for the Biology of Aging.

In the study, the researchers examined hundreds of donated healthy brains of older adults, people who died between 60 and 100 years old and were cognitively intact.

The study revealed a surprising and shocking difference: people between the ages of 85 and 100 years had significantly less expression of genes linked to neural overactivity than those who died decades earlier (between 60 and 80).

Our study raises the possibility that modulating excitation state can affect lifespan, Yankner said.

The thing that is super unexpected is . . . limiting neural activity is a good thing in healthy ageing. Its very counterintuitive, says Michael McConnell, a neuroscientist on the Lieber Institute for Mind Growth.

The line between normal brain activity and over-excitement still remains blurred. Working out your brain helps build new neural networks and activates neural growth factors that are positive, says Yankner.

These activities arent likely the same as deleterious brain activity, which manifests in things like muscle twitches, mood changes, seizures, Alzheimers, bipolar disorder, and other neurological disorders, he adds.

Yankner is quick to caution people from jumping the gun around the studys findings. Professor Yankner said: Its not yet clear whether or how a persons thoughts, personality or behaviour affect their longevity.

What sometimes gets lost in the coverage of ageing research are the few things you can do for which there is really strong evidence are good for ageing, Yankner says.

I think overactivity, out-of-control excitation its not good for the brain. You want the neurons to be active, when and where you want them to be active, not to be just generally firing off, mentioned Cynthia Kenyon, VP of Growing Old Analysis at Calico Labs.

The good news is the decline associated with brain activity is preventable.

The solution to an overworked brain is about altering your behaviour in simple ways just being conscious of moments of hyperactivity and slowing down or shifting your habits in a way that calms you down.

If work is grinding you down, interfering with sleep, and forcing you to push aside fun, paying attention now to your mental, physical, and emotional health may help keep your mind sharp as you get older,writesPatrick J. Skerrett, editor of theHarvard Heart Letter.

Start appreciating the moments of stillness in your life plan to disconnect and make time for yourself, sit with a book and just read, draw something, write a letter, journal. Or better yet, sit quietly and watch the thoughts that drift through your mind while you do some deep breathing.

Keeping that mental stillness and physical state of calm takes practice so prioritize downtime. Put in on your schedule. If you commit to doing one thing daily that promotes you relaxing and being more present and in your body, not your brain, you will see change.

Just start there and know that its not lazy its taking care of your brain and your emotion and physical well-being. Perhaps its the small-scale, daily choices that will make the difference for your mental health.

Originally published on Medium.

Follow us here and subscribe here for all the latest news on how you can keep Thriving.

Stay up to date or catch-up on all our podcasts with Arianna Huffington here.

Go here to see the original:
A Calm Mind Isn't Just a Nice-to-Have. It Can Actually Help You Live Longer. - Thrive Global

Read More...

The food of tomorrow the latest innovations from Europe’s foodtech sector – EU-Startups

October 27th, 2019 9:42 am

The 4.5 trillion global food industry is currently being influenced by numerous developments. From how food is designed, grown to how its consumed, the next generation of foodtech entrepreneurs are fighting for its piece of the pie. In the meantime, funding for food tech has skyrocketed and according to a report from Dealroom.co, foodtech has created 35 unicorns globally, with a combined value of 169 billion, of which 30 billion from Europe.

Few innovations introduced by European startups are currently shaping the future of food and give us a glimpse of what the future holds for the food industry.

The Magic of Food Science

One of the most interesting developments in the food industry is the introduction of new origins of food. Have you ever imagined that food could actually be made of electricity, air and water? Well, the Finnish company Solar Foods is here to make you believe it. They have produced a nutrient-rich protein, Solein, with air, water, and electricity as its main resources, laced with bacteria. Solar Foods makes Solein by extracting CO from the air using carbon-capture technology, and then combines it with water, nutrients and vitamins, using 100 percent renewable solar energy. Science fiction? Not so much. More like science fact. The end product looks and tastes like wheat flour, with 50% protein content and 510 % fat and 2025 % carbs. Producing Solein is entirely free from agriculture it doesnt require arable land or irrigation and isnt limited by climate conditions, said Solar Foods. And the best part of it? It will never run out.

Changing the way we source ingredients brings us to the next big thing in food science meat grown in a lab. Lab-grown meat is slowly becoming an alternative food option. A few years ago, Mosa Meat got the worlds attention when it announced the first-ever lab-grown meat burger from cow cells. The spin-off company from Maastricht University introduced the cultured meat in Europe and now, one of the newest companies to enter the market is Higher Steaks. Using state-of-the-art cell culture techniques, the UK-startup develops cell-based meat that has the potential to use 99% less land, 96% less water, 45% less energy and has up to 96% less greenhouse gas emissions, all the while tasting as conventional meat. The company uses stem cells obtained via a small blood sample or a skin patch and patented protocols licensed exclusively from its American university partners, allowing them to reprogramme stem cells into tissues like muscle and fat. A single blood sample could allow indefinite production of many meat products, its website states. Around the world, the demand for clean meat is consistently growing. Optimistically, their pork sausages will reach the market by 2021.

Diet for One and the Birth of Personalised Nutrition

One of the biggest advantages of nutrition in the modern age is personalisation. The basic idea is very simple: we all love food, but which food is good for us? Nutrino can give you the answer. The company unlocks the potential of nutritional data and provides its users with smart, personalised analyses of how their bodies interact with the foods they eat. By using machine learning and artificial intelligence, Nutrinos platform collects, processes, and analyses food-related data from its users, matches it with their ever-growing nutritional database and defines an individualised nutrition profile, called FoodPrint. By knowing your own FoodPrint, you will never again question what to eat. Closely related to the idea of eating the food that suits you best is the freedom to choose it. But in todays hectic world, we often forget about its importance.

Luckily, we have Gousto. Providingusers with 40 recipes on a weekly basis, this cook-at-home meal kit service delivers to your doorstep correctly portioned fresh ingredients matched to each recipe of your choice. Backed by an AI recipe recommendation tool, cooking at home has never been easier. Gousto has setanambitious target of delivering 400 million balanced and nutritious meals by 2025. As consumers growingrequest towards greater convenience in eating fresh foods and leading healthier lives increases, Gousto will reach its goal in no time.The same applies for Frichti, the most-funded food startup in France. Aiming to become the second kitchen of Parisians, Frichti offers healthy, seasonal meals at affordable prices, coupled with a fast delivery service. Now their recipe for success is expanding across Europe.

Innovations in Food Creation: 3D Food Printing

As the world goes digital, its time to digitise our kitchens as well. A Spanish startup called Natural Machines has introduced to the world a 3D food printer by the name of Foodini. Foodini uses fresh ingredients loaded into stainless steel capsules to make foods like pizza, pasta, quiche, pancakes or brownies. Not to be mistaken, a real pizza will not come of Foodini, but the dough for the pizza will be as it was prepared by an Italian grandmother. Foodini simply manages the difficult and/or time-consuming parts of handmade food preparation that often discourage people from cooking at home. The decorative potential of the device is also worth mentioning. From everyday foods to elaborate creations, each piece is visually appealing, inviting Michelin-star restaurants to boost their culinary creativity and elevate the restaurant experience.

The Rise of the Functional Beverage

One bottle. One meal. This is the new norm across Europe. Feed has made sure of that. The French startup has introduced a nutritionally complete and convenient meal packed in a bottle, containing just the right amount of protein, essential fats, carbohydrates, vitamins and minerals. All the nutrients ones body needs. Just add some water, shake it a bit and drink it. Feed is a new form of nutrition that offers you freedom. Healthy, convenient and economical, Feed will simplify your life,said Anthony Bourbon, CEO of Feed. Feed is vegan, gluten-free, lactose-free, GMO-free, nut-free and comes in the form of nutrition bars (100g), drinks (500ml), drink mixes and other products. Holding the reputation of delivering quick nutrition, it seems like meal replacements are here to stay. This just might be the end of food, as we know it.

The Future of Dining is Delivery

Welcome to Keatz, the virtual restaurant without guests. Under the slogan We cook, you enjoy. Keatz has been operating since 2016 as the latest addition to the restaurant delivery marketplace. As one of the pioneers of the Ghost restaurants concept, Keatz is up and running thanks to the ongoing popularity of food delivery platforms. Currently it operates a total of 10 virtual restaurants in Berlin, Munich, Madrid, Amsterdam and Barcelona, focusing exclusively on food made for delivery, with minimal capital expenditure and time. Their idea is rather simple. Why should you do groceries and spend time cooking if you can get a great meal delivered in 20 minutes? Living in an on-demand society, consumers are expecting to get what they need whenever they want, and wherever they want. Food is no exception to that.

Fixing Food Loss with Technology

1.3 billion tonnes of food is wasted every year, taking an enormous toll on the planet. At the same time, hunger remains one of the most urgent development challenges of our time. Luckily,consumers are becoming more environmentally conscious and plus, now they have technology to help them distribute the leftovers. This is what Karma is doing. Helping restaurants, cafes and shops to distribute their surplus food to Karma users who get to buy food at half price or more. By making a shared platform on which customers and food providers co-exist and benefit from each other, Karma has found an effective solution for tackling the issue of food waste. A win -win situation.Over 550 tonnes of food have so far been rescued and counting

Looking for startups innovating in a particular sector?If youre a corporate or investor looking for exciting startups in a specific market for a potential investment or acquisition, check out ourStartup Sourcing Service!

Read the rest here:
The food of tomorrow the latest innovations from Europe's foodtech sector - EU-Startups

Read More...

Cotton candy machines inspired this breakthrough in lab-grown meat – Digital Trends

October 27th, 2019 9:42 am

Growing meat in a lab has the potential to change the face of food production, offering an alternative to current meat production methods thats both greener and more ethical. But, shallow creatures that we are, lab-grown meat is going to have to taste like the real thing before a large number of people are willing to give it a try. Thats where new research from Harvards John A. Paulson School of Engineering and Applied Sciences (SEAS) comes into play.

Scientists in Professor Kit Parkers lab at SEAS have developed a new method of growing rabbit and cow muscle cells on edible gelatin scaffolds. Sound kinda gross? Perhaps, but the important thing is that the results more accurately mimic the texture and consistency of real meat.

One of the main challenges holding back industrial production of lab-grown or cultured meat is the requirement for muscle cells to attach to something when they are growing in 3D, Dr. Luke MacQueen, a research scholar in Parkers lab, told Digital Trends. We found a way to convert gelatin, an edible component of natural meats, into 3D fiber networks that allow muscle cells to attach and grow in 3D. The combination of cells and scaffolds makes a tissue. Meat is mostly skeletal muscle tissue so our scaffolds cultured with muscle cells are a first step toward cultured meat.

The nanofiber production process pioneered by the team was inspired by cotton candy machines. They begin by feeding a solution of gelatin dissolved in water into a rotating reservoir with small holes in its walls. The rotation forces the gelatin solution out through the holes, forming gelatin jets which travel through the air for around 10 centimeters before being dehydrated in an ethanol bath. Finally, the gelatin fibers are freeze-dried and stored for future use.

We have a lot of work in progress on this topic, MacQueen continued. Some of that involves new scaffold formulations, including plant proteins, and some involves new cell types, like stem cells and fat. We are planning to commercialize this research.

A paper describing this research, titled Muscle tissue engineering in fibrous gelatin: Implications for meat analogs, was recently published in the journal Nature Science of Food.

Follow this link:
Cotton candy machines inspired this breakthrough in lab-grown meat - Digital Trends

Read More...

The extracellular matrix, and how it keeps you in tip top shape – ZME Science

October 27th, 2019 9:42 am

Would you live in a city without streets? Or in a flat with no walls? Probably not and the cells in our bodies expect the same level of comfort. Today, were taking a look at the tissues that create and maintain an ideal working environment for our tissues: the extracellular matrix.

Weve had a look at the differences between animal and plant cells before (heres a refresher). One of the key differences between them is that plants reinforce their cells with thick, sturdy walls. These walls are why plant tissues such as wood can get so resilient. However, the reverse of the coin is that it also limits plant cells somewhat: a muscle made out of wood wouldnt be very effective.

Animals need cells that can perform a wide variety of activities, but these cells also need biological and mechanical support to perform their tasks. Thats where the extracellular matrix, or ECM, comes in.

The ECM is a complex mix of proteins and carbohydrates that fills the spaces between cells; it is comprised of the basement membrane and interstitial matrix. Going forward, Ill use the term ECM quite loosely to mean both the extracellular matrix and the interstitial matrix. If I dont mention the basement membrane specifically, Im probably talking about the interstitial matrix (as its the more dynamic and frankly more interesting half of the topic).

Think of the basement membrane as a sheet of plastic wrap the body stretches over every individual tissue or organ to keep everything tidy and in place. This membrane is made up of two layers of cells and its quite fibrous and hard to rip.

The interstitial matrix is, for lack of a better term, the goo that our cells live in. Most of the time, it looks and feels a bit like a clear gel. Its produced by the cells themselves, which secrete and release certain compounds around them.

The simplest definition of the extracellular matrix is that it represents the sum of non-cellular components present within all tissues and organs. As we go forward, keep in mind that the ECM isnt the same everywhere.

Although, fundamentally, the ECM is composed of water, proteins, and polysaccharides, each tissue has an ECM with a unique composition and topology that is generated during tissue development, Christian Frantz, Kathleen M. Stewart, Valerie M. Weaver, 2010.

Collagen, the most abundant protein in mammals, is the main component of the ECM. Outside the cell, collagen binds with carbohydrate molecules and assembles into long molecules called collagen fibrils. These fibrils extend through the ECM and lend flexibility and strength to the material, acting similarly to the role of rebar in reinforcing concrete (which is tough but inflexible). Collagen fibrils are flexible and tough to break, so theyre used to bind together the rest of the ECM. In humans, genetic disorders that affect collagen (such as Ehlers-Danlos syndrome) cause tissues to become fragile and tear easily.

While the ECM contains a wide range of proteins and carbohydrates, another important set of compounds alongside collagen are proteoglycans (groups of proteins tied to simple sugars). Proteoglycans come with many shapes and functions, depending on which proteins and sugars theyre made of, and perform a wide range of tasks in the ECM. They can also bind to each other, to collagen (forming cartilage), or to hyaluronic acid, making them even more versatile. As a rule of thumb, proteoglycans act as fillers and regulate the movement of molecules through the ECM among other functions.

Their overall structure looks like a tree: the sugar part of the polyglycans are twigs set on a branch (the protein), which ties to a trunk made out of polysaccharide (many-sugar) molecules. A class of proteins in the membranes of cells, called integrins, serve as connection ports between the membrane and material in the ECM (such as collagen fibers and proteoglycan-polysaccharide bundles). Beneath the membrane, integrins tie into the cells support girders (the cytoskeleton).

The type of ECM Ive described so far is your run of the mill variety that youll find in skin, around muscle fibers, in adipose tissue (fat), and so on. But each tissue has an ECM that fully supports its function blood plasma is the interstitial matrix of blood. Unlike the ECM of muscles, for example, which is meant to reduce friction and wear in the tissue, blood plasma primarily works as a medium to carry blood cells around. Blood vessels are coated with a basement membrane, and together, they form the ECM of blood. Each type of animal connective tissue has its own type of ECM, even bone.

Seeing as there are many types of ECM out there, it stands to reason that there are many functions they perform. However, by and large, there are a few functions that all ECMs fulfill.

The first and perhaps most important function is that they provide support to tissues, segregate (separate) them, and that they mediate intercellular communication. The ECM is also what regulates a cells dynamic behavior i.e. whether a cell moves around, and how. The ECM keeps cells in place so we dont simply unravel. The connections formed between the ECM and integrins on a cells membrane also function as signaling pathways.

It is also essential for the good functioning of tissues at large. The ECM creates and maintains the proper environmental conditions for cells to develop, multiply, and form functioning tissues. While the exact details are still unknown, the ECM has been found to cause tissue regrowth and healing after injury. In human fetuses, for example, the extracellular matrix works with stem cells to grow and regrow all parts of the human body. Fetuses can regrow anything that gets damaged in the womb, but since babies cant, we suspect that the matrix loses this function after full development. Researchers are looking into applying it for tissue regeneration in adults.

The ECM can also act as a storage space for various compounds. In joints, it contains more hyaluronic acid which in turn absorbs water and acts as a mechanical cushion. ECMs can also store a wide range of cellular growth factors and release them as needed. This allows our bodies to activate cell growth on a dime when needed without having to produce and ship these factors to a certain area.

It also seems to impact cell differentiation and gene expression. Cells can switch genes on or off depending on the elasticity of the ECM around them. Cells also seem to want to migrate towards stiffer areas of the ECM generally (durotaxis) from less-firm ones.

The ECM isnt very well known today, and it definitely goes unsung. But no matter how you cut it, it is a key part of biology as we know it today. Without it, both animals and plants would be formless, messy blobs quite literally. And I dont know about you but I love it when my tissues stay where theyre supposed to, the way theyre supposed to.

Continue reading here:
The extracellular matrix, and how it keeps you in tip top shape - ZME Science

Read More...

Speaking Multiple Sclerosis: A Glossary of Common Terms – Everyday Health

October 27th, 2019 9:42 am

Whether youve been recently diagnosed with multiple sclerosis (MS) or have been living with the condition for a while, chances are youll sometimes hear terms from your healthcare team that are new to you.

The following is a quick, alphabetical guide to the terminology you may need to know as you manage your condition:

Ankle-Foot Orthosis (AFO) A brace designed to support the position of the foot and motion of the ankle to compensate for nerve damage and muscle weakness in the area caused by MS and other movement disorders. An AFO is typically used to stabilize weak limbs or to reposition a limb with contracted muscles into a more normal position.

Autoimmune Disease Your immune system plays a major part of your bodys defense against bacteria and viruses by sending out cells to attack them once they enter your body. However, if you have an autoimmune disease, your immune system mistakenly attacks healthy cells in your body, causing them to weaken or break down. MS is thought to be just one example of an autoimmune disease. It has been suggested that in MS, your immune system may mistakenly attack the cells in your central nervous system.

Axon Long threadlike structures of nerve cells that send impulses to other cells in your body. Research suggests that damage to or loss of these fibers in progressive MS may be linked to worsening disability and more severe progression.

Central Nervous System (CNS) The group of organs in your body that includes the brain, spinal cord, and optic nerves. If you have MS, your bodys immune system may be working against the CNS, producing neurological symptoms such as muscle weakness and vision problems.

Cerebrospinal Fluid (CSF) A clear, colorless liquid that surrounds the brain and spinal cord to protect the CNS and assist in the circulation of nutrients and removal of waste products. In MS, damage to the myelin sheath of nerve cells causes certain types of proteins to be released into the spinal fluid. The presence of these proteins in the CSF, but not in the blood, may point to a diagnosis of MS.

Clinically Isolated Syndrome (CIS) A first episode of neurologic symptoms that lasts at least 24 hours and is caused by inflammation or demyelination (loss of the myelin that covers the nerve cells) in the CNS. People who experience CIS may or may not go on to develop MS. However, when CIS is accompanied by magnetic resonance imaging (MRI)detected brain lesions similar to those found in MS, you have a 60 to 80 percent chance of a second neurologic event and diagnosis of MS within several years, according to the National MS Society.

Cog Fog A commonly used term that refers to the cognitive changes experienced by many people with MS. According to MS Australia, approximately 50 percent of people with the condition will develop some degree of cog fog, or inhibited ability to think, reason, concentrate, or remember. For some, cognitive problems will become severe enough to interfere in a significant way with daily activities.

Corticosteroids (or Steroids) Prescription medication used to treat relapses in relapsing-remitting MS. Your doctor may prescribe intravenous (IV) corticosteroids if the symptoms of your relapse are causing significant problems, like poor vision or difficulty walking. These drugs work by suppressing the immune system and reducing inflammation in the CNS, and they may help relapse symptoms resolve more quickly. But they wont affect your ultimate level of recovery from a relapse or the long-term course of your MS. Methylprednisolone is a commonly used corticosteroid in MS.

Diplopia (or Double Vision) An eye problem in which you see two images of a single object. It may be present when only one eye is open (monocular) or disappear when either eye is closed (binocular). Diplopia is a common symptom of MS, and it occurs because of damage to the optic nerve.

Disease-Modifying Therapies (DMTs) Drugs designed to reduce new relapses, delay progression of disability, and limit new CNS inflammation in people with MS. Although there are multiple DMTs that have been approved by the U.S. Food and Drug Administration (FDA) for use in MS, these drugs generally work by reducing inflammation in nerve cells in theCNS.

Dysarthria A speech disorder caused by neuromuscular impairment and resulting in disturbances in motor control of the muscles used in speech. Its believed the demyelinating lesions in MS may result in spasticity, weakness, slowness, or ataxic incoordination of the lips, tongue, mandible, soft palate, vocal cords, and diaphragm, causing this speech impairment.

Dysphagia (Difficulty Swallowing) A condition that may occur in people with MS, leading to difficulty in eating solid foods or liquids, frequent throat clearing during eating or drinking, a feeling that food is stuck in the throat, or coughing or a choking sensation when eating or drinking. Its the result of nerve damage within the muscles that control swallowing.

Epstein-Barr Virus (EBV) A virus believed to be a possible cause or trigger for MS. Although the exact cause of MS remains unknown, researchers suggest an infectious agent may be involved in its development. Studies have found that antibodies (immune proteins that indicate a person has been exposed to a given virus) to EBV are significantly higher in people who eventually develop MS than in those who dont. Other research has noted that people with a specific immune-related gene and high levels of antibodies to EBV in their blood are 9 times more likely to develop MS than others.

Evoked Potentials A test that measures the speed of nerve messages along sensory nerves to the brain, which can be detected on your scalp using electrodes attached with sticky pads. Its sometimes used in the diagnosis of MS, because nerve damage can slow down the transmission of nerve signals. Evoked potential tests can indicate nerve pathways that are damaged prior to the onset of MS symptoms.

Exacerbation An occurrence of new symptoms or the worsening of old symptoms that may also be referred to as a relapse, attack, or flare-up. Exacerbations can be very mild, or severe enough to interfere with a person's ability to perform day-to-day activities.

Expanded Disability Status Scale (EDSS) A scale used for measuring MS disability and monitoring changes in the level of disability over time. Developed by neurologist John Kurtzke, MD, in 1983, the EDSS scale ranges from 0 to 10 in 0.5-unit increments (scoring is based on a neurological exam) and relies on walking as its main measure of disability. People with an EDSS of 1 have no disability and minimal loss of function, while those with an EDSS of 9.5 are confined to bed and totally dependent on others for functions of daily living.

Foot Drop (or Drop Foot) A symptom of MS caused by weakness in the ankle or disruption in the nerve pathway between the legs and the brain, making it difficult to lift the front of the foot to the correct angle during walking. If you have foot drop, your foot hangs down and may catch or drag along the ground, resulting in trips and falls. Foot drop can be managed with an AFO or other treatments.

Hematopoietic Stem Cell Transplantation (HSCT) A procedure designed to reboot the immune system, the National MS Society says, using hematopoietic (blood cellproducing) stem cells derived from a persons own bone marrow or blood. If your doctor recommends HSCT, youll undergo a chemotherapy regimen before these cells are reintroduced to the body via IV injection, where they will migrate to your bone marrow to rebuild the immune system.

John Cunningham (JC) Virus A common infection completely unrelated to MS that is found in as many as 90 percent of people, according to the UK's MS Trust. JC virus has no symptoms and is normally controlled by the immune system. However, if your immune system is weakened, the JC virus can reactivate, causing potentially fatal inflammation and damage to the brain known as progressive multifocal leukoencephalopathy (PML). Certain MS disease-modifying therapies have been linked with increased risk for PML.

Lhermittes Sign An electric shock-like sensation experienced by some with MS when the neck is moved in a particular way. The sensation can travel down to the spine, arms, and legs.

Lesion (or Plaque) Refers to an area of damage or scarring (sclerosis) in the CNS caused by inflammation in MS. These lesions can be spotted on an MRI scan, with active lesions appearing as white patches. With regular MRIs, a neurologist can tell how active your MS is.

Lumbar Puncture (or Spinal Tap) A procedure used for the collection of cerebrospinal fluid (CSF), sometimes done to help diagnose MS. For this procedure, your doctor will ask you to lie on your side or bend forward while seated, before cleansing an area of your lower back and injecting a local anesthetic. He will then insert a hollow needle and extract a small amount of spinal fluid using a syringe.

Magnetic Resonance Imaging (MRI) The diagnostic tool that currently offers the most sensitive noninvasive way of imaging the brain, spinal cord, or other areas of the body, according to the National MS Society. Its the preferred imaging method for diagnosis of MS and to monitor the course of the disease. MRI uses magnetic fields and radio waves to measure the relative water content in tissues, which is notable in MS because the layer of myelin that protects nerve cell fibers is fatty and repels water. In areas where myelin has been damaged by MS, fat is stripped away and the tissue holds more water. This shows up on an MRI as a bright white spot or darkened area, depending on how the images are made.

McDonald Criteria A guidance used in the diagnosis of MS, authored by an international panel of experts on the condition, originally in 2010. The guidance was updated in 2017. Among the key changes: advising for the use of brain MRI as part of the diagnostic process.

MS Hug A common symptom of MS. If you experience the MS hug, you may feel like you have a tight band around your chest or ribs, or pressure on one side of your torso. Some people find that it is painful to breathe. The MS hug can last for seconds, minutes, hours, or even longer.

Myelin A substance rich in lipids (fatty substances) and proteins that helps form the myelin sheath. In MS, particularly relapsing-remitting MS, an abnormal immune response produces inflammation in the CNS, effectively attacking the myelin in the cells.

Myelin Sheath An insulating layer of fatty substances and proteins that forms around the nerves in body, including those in the CNS. It allows electrical impulses to transmit quickly and efficiently along the nerve cells, but these impulses can be slowed if the sheath is damaged, causing MS.

Neurodegeneration Refers to the process by which the myelin sheath of cells in the CNS is damaged in MS. Its believed to be a major contributor to neurological disability in the condition, and may be the reason immune modulation treatments (disease-modifying therapy) are generally less effective in the progressive MS than in the relapsing-remitting MS.

Neurologist The point person for monitoring your MS treatment and managing MS symptoms. This specialist typically focuses on conditions affecting the CNS.

Neuropathic Pain A type of pain common in MS that results from changes or damage to the myelin sheath and the axons, or nerve fibers, it normally covers. MS-caused neuropathic pain may be chronic, intermittent, or occur only in response to a stimulus.

Neuropsychologist A specialist you may be referred to who helps you manage the cognitive effects of MS. Neuropsychological testing (or testing of the functioning of your brain) involves identifying memory or learning difficulties associated with MS. Cognitive rehabilitation may improve functioning.

Nociceptive Pain Caused by damage to muscles and joints, it can be either acute or chronic, and may not result from MS itself, but be caused by changes in posture or walking or the overuse of assistive devices in those with the condition.

Nystagmus A common eye abnormality in MS, its characterized by involuntary, rhythmic, back-and-forth motion of the eyeball, either horizontally or vertically. For those with nystagmus, the perception of the rhythmic movement of the surrounding stationary world (oscillopsia) can be disorienting and disabling.

Oligoclonal Bands (OCBs) Immunoglobulins, or proteins, that collect in blood plasma or cerebrospinal fluid (CSF). Although not every person with MS has OCBs, their presence can support a diagnosis of MS. Having OCBs is generally associated with a younger age of MS onset and a poorer prognosis.

Optic Neuritis An inflammatory condition that damages the optic nerve, a bundle of nerve fibers that transmits visual information from your eye to your brain, causing pain and temporary vision loss in one eye. Its been linked with nerve damage resulting from MS, and may be among the first symptoms a person with the condition experiences.

Pseudobulbar Affect (PBA) A neurologic effect experienced by roughly 10 percent of people with MS as well as some with Parkinsons disease or amyotrophic lateral sclerosis (ALS), according to the Multiple Sclerosis Association of America (MSAA). Its characterized by sudden, uncontrollable expressions of laughter or crying without an obvious cause, which can be distressing as well as embarrassing to those who experience it. PBA is believed to be a mood disorder related to the disruption of nerve impulses in the CNS, but its different from depression, which is also common in MS.

Pseudoexacerbation A temporary worsening of symptoms without actual myelin inflammation or damage. It is often triggered by other illnesses or infection, exercise, a warm environment, depression, exhaustion, and stress. Urinary tract infection (UTI) is the most common type of infection to cause a pseudoexacerbation.

Sclerosis A general hardening of the body tissue. The term multiple sclerosis refers to the multiple areas of scar tissue often called lesions that develop along affected nerve fibers and that are visible in MRI scans.

Spasticity A symptom of MS that causes your muscles to feel stiff, heavy, or difficult to move. When a muscle spasms, youll experience a sudden stiffening that may cause a limb to jerk. This may be painful.

Trigeminal Neuralgia (or Tic Douloureux) A type of neuropathic pain that occurs on the face (usually on one side only). Its a known symptom of MS, and you may experience it in your cheek; upper or lower jaw; inside the mouth; or in the area around your eyes, ears, or forehead. In MS, its typically caused by damage to the myelin sheath around the trigeminal nerve, which among other functions controls the muscles used in chewing. The condition is triggered by everyday activities, like tensing facial muscles while shaving or when chewing.

Vertigo An intense sensation of the surrounding environment spinning around one. In MS, vertigo is typically caused by growth of an existing lesion or development of a new lesion on the brain stem or cerebellum, the area in the brain that controls balance. It can also be a symptom of a problem with the inner ear, or it can be side effect of medication used to treat MS or other health conditions you may have.

See the article here:
Speaking Multiple Sclerosis: A Glossary of Common Terms - Everyday Health

Read More...

Do transhumanists need their own bill of rights? – Quartz

October 27th, 2019 9:41 am

In todays future-facing era, phenomena once relegated to the world of science fiction are starting to edge their way into reality.

We have scientists growing brains from stem cells in petri dishes; robots are being granted national citizenship; virtual intelligences experience and expressanger.

For the past 50 years, the microprocessorthe chip that processes information in a computerhas doubled in capacity at least everyyear to two years. Experts predict that machine intelligence will be smarter than humans by 2030.

So heres my question: When the machines weve created possesses an intelligence that equals ours, will they deserve our protection?

Will they desire it? Maybe even demand it?

This should be your question, too. Because in a little longer than a decades time, well need answers if want to avert moral and civil rights mishaps.

Futurists and technologists have been working to prepare the world for radical new sapient technologies and intelligences with publications such as the Cyborg Bill of Rights V1.0 which advocates equality for mutants.

Beyond the microprocessor, instrumental in catapulting machine intelligence to new levels through its ever-increasing speed for calculations, weve seen accelerating advances in genetic editing, stem-cell research, and 3D bioprinting, each which will help to create entities that have both consciousness and intelligence. This year 3D bioprinting has come so far that a team of Israeli scientists were able to successfully print part of a human heart.

Netflix released a popular four-part documentary series called Unnatural Selection on the topic.

Scientists are already wading into murky waters when it comes to the rights of these new intelligent organisms that we create. AtYale University brains from deceased pigs are being stimulated in a vat, which has prompted controversy in the animal rights world.

Do the brains of these animals, once dead, now represent live animals? And if so, do they receive the same legal rights that have informed laws that protect animals against harmful animal testing and animal cruelty?

As a result of these emerging ethical issues, were seeing more debates about new terms of futurist-oriented rights.

But the fact remains that there are few, if any, actual rules for most of our new scientific realities.

This is largely what inspired me to come up with theTranshumanist Bill of Rights, which Wiredpublished in full in 2018. The document recently underwent its third rendition via crowdsourcing.

When the machines weve created possesses an intelligence that equals ours, will they deserve our protection?

Like many of the cyborg bills that existthere are about half a dozen significant ones floating around the internetthis bill includes legal protections for thinking robots, gender explanations for virtual intelligences, laws for genetically engineered sapient creatures, defense of freedoms allowing biohackers to modify their bodies, and many other protections. It even includes policies to fight off environmental destruction and planetary existential threats such as asteroids, plagues, nuclear war, and global warming.

In 2015, Iwalked up to the US Capitol building holdinga single-page print out of the document I had written. The machine gun-toting police standing guard just feet away from me threatened arrest, but there was little need; the taped-on page quickly fell off the building, fluttered off the wall in the wind.

I wasnt arrested. The police and journalists surrounding me chuckled at the bungled ceremonial moment.

I recall that I couldnt help but smile myself at the idea of getting a futurist bill of rights to become a fixed part of US governing policy at the time.

But four years later, with machines showing ever increasing sophisticationhumans are even marrying robotsin some parts of the worlda bill of rights is not as wild as it once sounded. We could easily say the same for genetically-modified babies being born, which happened for the first time inChinalast year.

In my work, I meet with people around the world who are interested in answering not if we need a futurist bill of rights, but when we will need it, from Harvard Universitys Kennedy School of Government to theCato Institute to theWorld Economic Forumto European ministries.

If you look through the various cyborg-inspired bills of rights already out there, youll find that a major goal is to include cyborg and transhumanist rights in the UNs 1948Universal Declaration of Human Rights one day.

The ideas of personhood, a right to education, and freedom of speech were once considered unattainable in some countries. Now these basic human rights are common, and at least some of this change is due to the powerful legal influence of the UNs universal bill, often seen as a blueprint for governments and laws around the globe.

Interestingly, one of the challenges of getting a transhumanist bill of rights taken seriously comes from minorities groups, when its perceived that futurist rights will undermine movements of historically marginalized peoples. While plenty of transhumanists are members of the LGBTQ community, the community has been reluctant to wander intofuturist LGBTQissues, such as nongender roleplaying as different species in virtual environments.

LGBTQ friends of minewhile often sympathetic to transhumanist goalshave told me that they believe that after their historic quest for rights in America especially, they still need to focus on progress for their own movement and its goals. They perceive a futurist bill of rights as a distraction.

I respect and agree with this. Minorities in the US and around the world face social discrimination and violations of rights that warrant our attention. But it wont slow down the trajectory of radical technologies, which is spurring a growing futurist community to call for its own set of rights, rules, and protections.

I understand that at times it seems preposterous to believe the world will need to consider whether super intelligentrobots can vote, or whether human heads can betransplantedto waiting tech-engineered bodies, or if four years of college education canbe downloadedinto human brains.

But these realities are likely to occur long before the century is out.

If society doesnt accept that new sapient lifeformswhether its an autonomous digital avatar living in a supercomputer, or a biological creature with human-level intelligence that genetic editing createdalso need rights, or that new forms of engineered conscious intelligences will walk among humans on Earth as a result of scientific progress, society will undergo another wave of civil strife as we scramble to play catch-up to whats fair and moral.

At the very least, societies and governments need more comprehensive plans to formally deal with these new realities. That begins with a Congressional dialogue and forming preliminary legal documents outlining potential rights for the evolving future.

Ultimately, it comes down to how humans believe new intelligent life deserves to be treated.

See the article here:
Do transhumanists need their own bill of rights? - Quartz

Read More...

UI-led neuropathy consortium receives grant renewal from National Institute of Health – UI The Daily Iowan

October 25th, 2019 9:45 pm

The Inherited Neuropathy Consortium led by University of Iowa neurologist Michael Shy has received a grant renewal to continue studying inherited neuropathies.

The Carver College of Medicine is pictured on Wednesday, April 4, 2018.

Gaoyuan Pan

The Carver College of Medicine is pictured on Wednesday, April 4, 2018.

Gaoyuan Pan

Gaoyuan Pan

The Carver College of Medicine is pictured on Wednesday, April 4, 2018.

As clinical research of medical technology advances, so will the understanding of genetic neurological diseases. The National Institute of Health has renewed the University of Iowas grant to study inherited neuropathic diseases.

The Inherited Neuropathy Consortium, located in the UI Carver College of Medicine, recently received a five-year $7.2 million grant renewal to continue researching inherited peripheral neuropathies in the hope of finding a cure for related diseases.

Peripheral neuropathies are disorders affecting the nerves that spread from someones back to their hands and feet, which can cause weakness and balance problems, UI neurologist Michael Shy said. Although these disorders have many causes, he said, a common cause is a genetic mutation that can disrupt the nerves.

Shy said the diseases are referred to as Charcot-Marie-Tooth type 1 or type 2, depending on which part of the nerve the disease affects. These diseases are fairly common and affect one in 2,500 people, he added.

Up until 1990, there were no known genetic causes for any of these, although it was known that the diseases could be genetic, Shy said. Now theres mutations in over 100 different genes that can cause these disorders.

The consortium works with other institutions around the world to determine how these diseases change over time, identify other genetic causes of Charcot-Marie-Tooth, and train physicians to study and treat the diseases, Shy said.

With the grant renewal, the consortium will continue its study of how Charcot-Marie-Tooth changes over time through using different outcome measurements they have developed and new instruments allowing them to measure outcomes in infants, Shy said.

RELATED: UI doctors prepare to study obscure leading cause of death in refractory epilepsy

The grant will also allow researchers to continue to identify and study biomarkers in patients blood that are common for Charcot-Marie-Tooth, he said.

Even though clinical trials have been developed to treat the diseases, there is no cure, Shy said. The clinic emphasizes genetic counseling to help people understand their condition and the potential it has to pass on to other generations, he said.

Counselors meet with families to discuss genetic testing options, provide an understanding of what their insurance will cover, and an understanding of the various lab testing they will receive, said Shawna Feely, genetic counselor and clinic coordinator.

Feely is the consortiums project manager and oversees the 20 sites involved. She helps research teams navigate protocols, understand the testing, and create uniformity in the way clinical trials are conducted.

RELATED: University of Iowa receives grant to improve statewide-maternal-health

Any time youre giving a genetic diagnosis, there can be an emotional element to the person or family in terms of family dynamics or feeling guilt that someones passed a genetic disease on, and so genetic counselors part of the counseling part is to help families cope, Feely said.

Genetic counselor Tiffany Grider said in an email to The Daily Iowanthat a common question from patients is whether or not their child will have the same condition, and whether theres a treatment for it.

Researchers like Dr. Shy have spent decades learning the exact biological mechanism for how these diseases happen, Grider said.

With the developing research and the grant, the future of the clinic and genetic testing will be in the hands of the next generation, Shy said.

Its this next generation of scientists who are going to take this to the clinic, so these are going to become treatable diseases, Shy said. And we need that generation to be well-trained to be able to develop [treatments].

Read the original:

UI-led neuropathy consortium receives grant renewal from National Institute of Health - UI The Daily Iowan

Read More...

Advanced Nerve & Health Center helps breast cancer survivor reverse her neuropathy – KHOU.com

October 25th, 2019 9:45 pm

HOUSTON Deborah Brancato has worked as a flight attendant for 25 years, but after undergoing chemotherapy to treat breast cancer, she developed neuropathy. The pain in her feet was so bad she was not able to stand for long periods of time and couldn't wear the required closed-toed shoes that were part of her uniform.

Brancato needed to find a solution to treat the pain she experienced from neuropathy. She found help at Advanced Nerve and Health Center, where patients of Dr. Bao Thai are seeing amazing results. Dr. Thai has developed a non-invasive, pain free treatment that helps the body repair nerves without surgery or medication.

Dr. Thai is a pioneer in this field, and has studied all over Europe and Asia exploring technologies and processes. He conducted his own research and found that the body wants to heal the nerve, and over time it will heal.

The Advanced Nerve and Health Center has a limited time offer for Great Day Houston viewers. For $39, the first 17 callers will get an in-office consultation, a copy of Dr. Thai's "Healthy Diet to Heal Nerve Pain" book, and a diagnostic nerve test to see if they can help. This is a $399 value.

Call Advanced Nerve and Health Center now at 832-626-1260.

Advanced Nerve and Health Center is located at 8558 Katy Freeway, Suite 116, Houston, TX 77024.

For more information, log on to NerveAndHealth.com.

This content is sponsored by: Advanced Nerve and Health Center.

Here is the original post:

Advanced Nerve & Health Center helps breast cancer survivor reverse her neuropathy - KHOU.com

Read More...

Cardiac Autonomic Neuropathy Treatment Market expected to Witness a Sustainable Growth over 2017 2025 – Health News Office

October 25th, 2019 9:45 pm

In 2018, the market size of Stroke Prevention in Atrial Fibrillation (SPAF) Treatment Market is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment .

This report studies the global market size of Stroke Prevention in Atrial Fibrillation (SPAF) Treatment , especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

Request Sample Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2525974&source=atm

This study presents the Stroke Prevention in Atrial Fibrillation (SPAF) Treatment Market production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Stroke Prevention in Atrial Fibrillation (SPAF) Treatment history breakdown data from 2014 to 2018, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2018.

In global Stroke Prevention in Atrial Fibrillation (SPAF) Treatment market, the following companies are covered:

Boehringer IngelheimBayerJohnson & JohnsonBristol-Myers SquibbPfizerDaiichi-SankyoGilead

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeOral Direct Thrombin InhibitorsOral Direct Factor Xa Inhibitors

Segment by ApplicationHospitalsClinicsAmbulatory Surgical Centers

Make An EnquiryAbout This Report @ https://www.researchmoz.us/enquiry.php?type=E&repid=2525974&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Stroke Prevention in Atrial Fibrillation (SPAF) Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Stroke Prevention in Atrial Fibrillation (SPAF) Treatment , with price, sales, revenue and global market share of Stroke Prevention in Atrial Fibrillation (SPAF) Treatment in 2017 and 2018.

Chapter 3, the Stroke Prevention in Atrial Fibrillation (SPAF) Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Stroke Prevention in Atrial Fibrillation (SPAF) Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2018.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2018.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2525974&licType=S&source=atm

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2018.

Chapter 12, Stroke Prevention in Atrial Fibrillation (SPAF) Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2024.

Chapter 13, 14 and 15, to describe Stroke Prevention in Atrial Fibrillation (SPAF) Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Read the rest here:

Cardiac Autonomic Neuropathy Treatment Market expected to Witness a Sustainable Growth over 2017 2025 - Health News Office

Read More...

PDF Report : Diabetic Neuropathy Market 2019 || Comprehensive Analysis of the market with Competitive Landscape and Forecasts To 2028 – Tech News…

October 25th, 2019 9:45 pm

TheDiabetic Neuropathy Market is a professional and in depth market reportthat focuses on primary and secondary drivers, possible sales volume, market share, leading segments, market size and geographical analysis of the market. It shows that the increase in market value is generally attributed to the increasing growth of the applicable industries and the subsequent increase in demand for applications. The Diabetic Neuropathy market analysis examines the different segments that are relied on to witness the fastest growth in the approximate forecast frame. The competitive landscape section of the Diabetic Neuropathy report provides a clear insight into the market share analysis of major industry players.

Diabetic Neuropathy Market: Scope of the Report :

This report provides an all-inclusive environment of the analysis for the Diabetic Neuropathy Market. The market estimates provided in the report are the result of in-depth secondary research, in-house expert reviews, and primary interviews. These market estimates have been considered by studying the impact of various social, political and economic factors along with the current market dynamics affecting the Diabetic Neuropathy Market development. In addition to the description of the market, which includes market dynamics, the chapter includes Porters Five Forces analysis which explains the five forces; namely buyers bargaining power, suppliers bargaining power, the threat of new entrants, threat of substitutes, and degree of competition in the Diabetic Neuropathy Market. The report also focuses on the competitive landscape of the Diabetic Neuropathy Market.

For Better Understanding Go With this Free Sample Report Enabled with Respective Tables and Figures:https://marketresearch.biz/report/diabetic-neuropathy-market/request-sample

Diabetic Neuropathy Market: Competitive Landscape

The market analysis entails a section solely dedicated to major players in the Diabetic Neuropathy Market wherein our analysts provide an insight into the financial statements of all the major players, along with its key developments, product benchmarking and SWOT analysis. The Company Profile section also comprises a business overview and financial information. The companies that are provided in this section can be customized according to the clients requirements.

There are some key players Pfizer Inc, Eli Lilly and Company, Actavis Pharma Inc, Cephalon Inc, Meda Pharma GmbH, GlaxoSmithKline plc, NeuroMetrix Inc, Johnson & Johnson Inc, Boehringer Ingelheim GmbH, Astellas Pharma Inc.

Diabetic Neuropathy Market Segments:

Segmentation on the basis of disorder type:

Peripheral neuropathyAutonomic neuropathyProximal neuropathyFocal neuropathySegmentation on the basis of treatment:

RadiotherapyPhysiotherapy

Key Questions Answered by This Report:

How did the market evolve and what is the market status in 2019?

What are the drivers and restraints of the Market?

What are the opportunities for growth within the market and where do the major threats lie?

How will each submarket segment grow in the near future and how much market value will each segment generate for 2019 2028?

How the political, economic, social, and technology factors influence the submarkets and regional market?

How will individual leading Worldwide markets perform over the forecast period, and what are their drivers and restraints?

What have been the major developments of the leading Worldwide markets over recent years, leading to their current market status?

How will the market shares of the regional and leading Worldwide markets evolve by 2019 2028, and which geographical region will lead in 2019 2028?

Who are the key players within the market, and what are their strategies over the forecast period?

Share Your Questions Here For More Details On this Report or Customizations As Per Your Need:https://marketresearch.biz/report/diabetic-neuropathy-market/#request-for-customization

In more detail, the chapters of this report contain the following topics:

Chapter 1 It consists of research objective and assumption, research objectives of the report

Chapter 2 Introduces the market; discusses the different segmentations of the market; summaries the report

Chapter 3 Includes market drivers, restraint, opportunity, and trends contributing to the growth of the market. The dynamic section of the report also includes DR Impact Analysis, Opportunity Orbit, PEST Analysis, and Porters Five Analysis.

Chapter 4 Studies the global market, providing market shares and sales figures. The chapter also analyses market forecasts, factors enabling growth, and the future of the market, covering the period 2018-2029. Furthermore, it provides in-depth detailed analyses and forecasts of the submarkets.

Chapter 5 provides an in-depth and thorough analysis of the regional and Worldwide markets. The chapter continues by supplying market forecasts, details on growing regions, factors enabling the growth, drivers, and restraints on a Worldwide basis, developments over 2015 and their influence over the forecast period, and future market predictions, covering the period 2018-2029.

Chapter 6 Identifies, discusses and analyzes the leading players in the market, as well as innovative, growing companies that will impact the future of the industry.

Chapter 7 Explains the research methodology the company follows to create, enriched insights to clients from millions of data points.

Inquire/Speak To Expert for Further Detailed Information About Diabetic Neuropathy Report:https://marketresearch.biz/report/diabetic-neuropathy-market/#inquiry

Excerpt from:

PDF Report : Diabetic Neuropathy Market 2019 || Comprehensive Analysis of the market with Competitive Landscape and Forecasts To 2028 - Tech News...

Read More...

Surviving breast cancer what comes next? – Hudson Valley 360

October 25th, 2019 9:45 pm

October is Breast Cancer Awareness Month. In some ways, the month is a celebration of the many advances made toward diagnosing and treating breast cancer at its very earliest stages. With these earlier identifications come the expectations for more favorable treatment and survival outcomes.

That said, when a cancer diagnosis is delivered, the individual receiving it often hears nothing but I have cancer. Words like these can be overwhelming. It begins a search to gather and develop the most competent team to lead you through this journey.

There are many options when considering breast cancer surgery. Those are for you and your surgical team to examine. Perhaps you have chosen to pursue a lumpectomy or a mastectomy. These procedures might include lymph nodes being removed in the axilla (the armpit), to discover if a cancer has spread elsewhere.

But what happens after a tumor has been removed? Surgical intervention can deliver a whole new set of concerns including:

n Tissue adhesions that can lead to postural changes

n Impaired shoulder function

n Pain and subsequent movement compensations

n Seromas

n Hematomas

n Serratus anterior weakness

n Axillary web syndrome/cording (scarring or connective tissue under the arm that can limit range of motion)

Lymphedema is also a common side effect following breast cancer surgery. It occurs after the lymph nodes have been removed or damaged, impairing normal lymphatic flow in the arm, which causes the arm to swell.

Your plan of care might also include radiation or chemotherapy. If radiation is part of your treatment, there can be temporary tissue adhesions; reduced shoulder and trunk range of motion; inflammatory edema (swelling caused by excess fluid); and pain. You may also experience permanent changes called radiation fibrosis, which is scar tissue that can occur in the breast and chest wall.

If your oncology team decides chemotherapy is warranted, challenges from the treatment can include pain; fatigue; poor tolerance to activity; neuropathy; weakness; and an increased risk of cardiovascular disease.

Regardless of your breast cancer treatment approach, every survivors plan for recovery should include treatment for whatever physical changes you may experience. It is imperative to see a physical therapist and certified lymphedema therapist early on to ensure the best results.

A therapist trained in breast cancer rehabilitation can work with you to:

n Address shoulder, complex movement, and soft tissue disorders

n Improve your comfort and function during and following breast reconstruction

n Address effects of radiation

n Reduce fatigue and weakness

n Develop an individualized home exercise program

St. Peters Health Partners Patient Therapies has a variety of outpatient physical therapists at locations throughout the Capital District, accepting all insurances and providing quality one-on-one treatment. Our staff works closely with your oncology and/or primary care team to help decrease pain, improve flexibility, and reduce effects of scar tissue adhesions/radiation fibrosis.

If you are seeking treatment for lymphedema, our therapists have received specialized training in manual lymph drainage and compression bandaging. We have the longest operating lymphedema management program in the Capital District.

For information, call 518-268-5749 or visit us at http://www.sphp.com/patient-therapies.

See more here:

Surviving breast cancer what comes next? - Hudson Valley 360

Read More...

Page 839«..1020..838839840841..850860..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick